Omega Diagnostics Group PLC (LSE:ODX) - Share price - Overview

Stock Report

Omega Diagnostics Group PLC ODX

Last Price
GBX17.85

Day Change
-0.40|-2.19%

As of 24/02/2017
11:21:43 GMT | GBX
Minimum 15 Minutes Delay.

Last Close18.25p
Day Range17.85 - 17.85
Mkt Cap19.85Mil
52-Wk Range13.75 - 21.00
Yield %0.00
ISINGB00B1VCP282
Volume15,000
P/E35.70
P/S1.52
P/CF13.41

Share Price

Total Returns 23/02/2017

 Chg (%)  
More ...
Omega Diagnostics Group PLC5.80 
FTSE 100 TR GBP2.45
 
Financials
201420152016
More ...
Income Statement
Turnover11.5912.1112.74
Operating Profit0.530.670.67
Net Profit0.690.740.57
Reported EPS0.700.700.50
Balance Sheet
Current Assets7.236.576.15
Non Current Assets14.7716.0717.63
Total Assets21.9922.6423.78
Current Liabilities2.171.971.77
Total Liabilities3.533.823.59
Total Equity18.4618.8120.19
Cash Flow
Operating Cash Flow1.661.251.25
Net Change in Cash3.00-1.02-0.73
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20171.141.10120.0016.590.14--
20181.281.2513.6414.601.07--

Company Profile

Omega Diagnostics Group PLC manufactures, develops & distributes medical diagnostic products. It is also engaged in the research, development, production and marketing of in-vitro allergy tests used by doctors to diagnose patients with allergies.

Sector

Medical Instruments & Supplies

Market Position

1348 of 1852 Companies

Index

FTSE AIM All Share

Outlook

(21/11/2016) "...the outlook for the rest of the financial year is encouraging within our core business with revenue and adjusted profit before tax expected to be at the higher end of market expectation due, in part, to favourable currency movements"

Next Event 31/03/2017

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)14.7818.0016.26
Div Yld (E)0.001.914.07
PEG (E)0.790.821.10
ROCE7.9135.51109.55
Op Mrgn5.26-14.24-16.88
EPS Grwth18.6836.2231.59
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. David Evans
Chief Executive OfficerMr. Andrew Shepherd
Finance Director & Company SecretaryMr. Kieron Harbinson
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.